- 2025-04-12 17:54SARS-CoV-2 3CLpro-IN-26
- 2025-04-12 17:54hsa62 780822-35-7
- 2025-04-12 17:54DBCO-PEG3-oxyamine-Boc hydrochloride
- 2025-04-12 17:54Cdk2/Cyclin Inhibitory Peptide I 237392-84-6
- 2025-04-12 17:54MC1568 852475-26-4
- 2025-04-12 17:54MMV666810 1450666-97-3
- 2025-04-12 17:54GSK3335103 1893340-21-0
- 2025-04-12 17:54KRAS inhibitor-33
- 2025-04-12 17:54DB-008
- 2025-04-12 17:54Intoplicine dimesylate (RP 60475 dimesylate) 133711-99-6
- 2025-04-12 17:54Naftifine-d3 hydrochloride (Naftifine d3 hydrochloride) 1246833-81-7
- 2025-04-12 17:54PPARγ agonist 9 474329-47-0
- 2025-04-12 17:54Antitubercular agent-33 476317-29-0
- 2025-04-12 17:54ARN14494 1037837-27-6
- 2025-04-12 17:54Gatifloxacin (AM-1155) 112811-59-3
- 2025-04-12 17:54Oxaline 55623-37-5
- 2025-04-12 17:54HaloPROTAC-E 2365478-58-4
- 2025-04-12 17:54SARS-CoV-2 3CLpro-IN-25
- 2025-04-12 17:542′,3′-Dideoxy-3′-fluoro-5-methylcytidine 115249-95-1
- 2025-04-12 17:54DBCO-PEG3-oxyamine 2748394-67-2
